Cargando…

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia

BACKGROUND: The burden of influenza is increasingly recognised in Africa. The WHO recommends introducing influenza vaccination to high-risk groups: pregnant women, children <5 years, and the elderly. The Gambia currently has no influenza vaccination policy, but the NASIMMUNE study, a clinical tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Armitage, Edwin P., Camara, Janko, Bah, Sulayman, Forster, Alice S., Clarke, Ed, Kampmann, Beate, de Silva, Thushan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858151/
https://www.ncbi.nlm.nih.gov/pubmed/29483030
http://dx.doi.org/10.1016/j.vaccine.2018.02.037
_version_ 1783307600887021568
author Armitage, Edwin P.
Camara, Janko
Bah, Sulayman
Forster, Alice S.
Clarke, Ed
Kampmann, Beate
de Silva, Thushan I.
author_facet Armitage, Edwin P.
Camara, Janko
Bah, Sulayman
Forster, Alice S.
Clarke, Ed
Kampmann, Beate
de Silva, Thushan I.
author_sort Armitage, Edwin P.
collection PubMed
description BACKGROUND: The burden of influenza is increasingly recognised in Africa. The WHO recommends introducing influenza vaccination to high-risk groups: pregnant women, children <5 years, and the elderly. The Gambia currently has no influenza vaccination policy, but the NASIMMUNE study, a clinical trial of intranasal live attenuated influenza vaccines (LAIV) in young children provided an opportunity to study maternal attitudes towards LAIV for the first time in sub-Saharan Africa. We assess acceptability of LAIV, influenza knowledge and attitudes towards influenza vaccination in Gambian women. Additionally, we investigate predictors of willingness to receive influenza vaccine (intent) in pregnancy or seasonally for children <5. METHODS: A cross-sectional survey was conducted in Gambian women at two urban health facilities. To assess LAIV acceptability, the exposure group (women whose children had received LAIV during the NASIMMUNE study) were compared to a control group (women whose children were not enrolled in the NASIMMUNE study). Demographics and health belief constructs were analysed as predictors of influenza knowledge and vaccine intent. FINDINGS: The exposure group (n = 150) expressed a higher preference for a nasal spray vaccine than an injection compared to the control group (n = 304) (93.3% vs. 34.9%, OR = 26.15, p < 0.0001). Those in the exposure group who preferred the nasal spray found it less distressing, safer or equally safe, and easier or equally easy to give (all p < 0.001) than injections. Influenza knowledge increased with education level (p = 0.006 for higher education vs. none), and varied between sites (p = 0.0005). Vaccine intent was >98%, but no association with influenza knowledge or difference between groups was observed. Various health belief constructs were associated with vaccine intent. CONCLUSION: LAIV acceptability was higher in those with first-hand experience. Influenza vaccine intent was also high. Incorporation of seasonal LAIV into the childhood immunisation schedule in The Gambia would be feasible, particularly if combined with community-based health education.
format Online
Article
Text
id pubmed-5858151
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-58581512018-03-20 Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia Armitage, Edwin P. Camara, Janko Bah, Sulayman Forster, Alice S. Clarke, Ed Kampmann, Beate de Silva, Thushan I. Vaccine Article BACKGROUND: The burden of influenza is increasingly recognised in Africa. The WHO recommends introducing influenza vaccination to high-risk groups: pregnant women, children <5 years, and the elderly. The Gambia currently has no influenza vaccination policy, but the NASIMMUNE study, a clinical trial of intranasal live attenuated influenza vaccines (LAIV) in young children provided an opportunity to study maternal attitudes towards LAIV for the first time in sub-Saharan Africa. We assess acceptability of LAIV, influenza knowledge and attitudes towards influenza vaccination in Gambian women. Additionally, we investigate predictors of willingness to receive influenza vaccine (intent) in pregnancy or seasonally for children <5. METHODS: A cross-sectional survey was conducted in Gambian women at two urban health facilities. To assess LAIV acceptability, the exposure group (women whose children had received LAIV during the NASIMMUNE study) were compared to a control group (women whose children were not enrolled in the NASIMMUNE study). Demographics and health belief constructs were analysed as predictors of influenza knowledge and vaccine intent. FINDINGS: The exposure group (n = 150) expressed a higher preference for a nasal spray vaccine than an injection compared to the control group (n = 304) (93.3% vs. 34.9%, OR = 26.15, p < 0.0001). Those in the exposure group who preferred the nasal spray found it less distressing, safer or equally safe, and easier or equally easy to give (all p < 0.001) than injections. Influenza knowledge increased with education level (p = 0.006 for higher education vs. none), and varied between sites (p = 0.0005). Vaccine intent was >98%, but no association with influenza knowledge or difference between groups was observed. Various health belief constructs were associated with vaccine intent. CONCLUSION: LAIV acceptability was higher in those with first-hand experience. Influenza vaccine intent was also high. Incorporation of seasonal LAIV into the childhood immunisation schedule in The Gambia would be feasible, particularly if combined with community-based health education. Elsevier Science 2018-03-20 /pmc/articles/PMC5858151/ /pubmed/29483030 http://dx.doi.org/10.1016/j.vaccine.2018.02.037 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Armitage, Edwin P.
Camara, Janko
Bah, Sulayman
Forster, Alice S.
Clarke, Ed
Kampmann, Beate
de Silva, Thushan I.
Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
title Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
title_full Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
title_fullStr Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
title_full_unstemmed Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
title_short Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
title_sort acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in the gambia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858151/
https://www.ncbi.nlm.nih.gov/pubmed/29483030
http://dx.doi.org/10.1016/j.vaccine.2018.02.037
work_keys_str_mv AT armitageedwinp acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia
AT camarajanko acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia
AT bahsulayman acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia
AT forsteralices acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia
AT clarkeed acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia
AT kampmannbeate acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia
AT desilvathushani acceptabilityofintranasalliveattenuatedinfluenzavaccineinfluenzaknowledgeandvaccineintentinthegambia